| | |
ASPsiRNA information |
siRNA Id: | aspsirna1751
|
siRNA Name: | BetaS(G:U)-siRNA
|
Mismatch information |
Wild siRNA (As strand 3'->5'): | ACUGAGGACUCCUCUUCAG
|
ASP-siRNA (As strand 3'->5'): | ACUGAGGACACCUCUUCAG
|
Mismatch position in siRNA: | A10C,G1U |
Gene Information |
Gene Name | Hb beta-chain (HBB) |
Target Sequence (5'->3'): | ATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCC
|
Wild allele (5'->3'): | UGACUCCUGAGGAGAAGUC
|
Mutant allele (5'->3'): | UGACUCCUGUGGAGAAGUU
|
Position of siRNA on target gene: | 61-79
|
Respective Gene/Protein Resources |
GenBank Accession: | NM_000518.4 |
Cytogenic location: | 11p15.4 |
Chromosomal coordinates: | 11:5,246,695-5,248,300 |
UniProt ID: | P68871 |
HUGO ID: | 4827 |
Reference SNp(RefSNP): | rs33987957 |
Disease/Mutation information |
Target Mutation: | c.365A>T (p.Glu122Val)
|
Matation type/variant: | single nucleotide variant/Missense variant
|
Mutation at gene level: | NG_000007.3:g.71939A>T
|
Pathogenic status of mutation: | Pathogenic
|
Disease: | Sickle cell anemia |
Clinical Resources |
ClinVar ID: | 15110 |
KEGG disease ID: | H00229 |
OMIM ID: | 603903 |
COSMIC: | HBB |
DECIPHER: | HBB |
GeneTests: | HBB |
ASP siRNA details |
Mutant allele (5'->3'): | UGACUCCUGUGGAGAAGUU
|
ASP-siRNA (As strand 3'->5'): | ACUGAGGACACCUCUUCAG
|
Percentage efficacy of ASP-siRNA for mutant allele: | NA
|
Wild allele (5'->3'): | UGACUCCUGAGGAGAAGUC
|
ASP-siRNA (As strand 3'->5'): | ACUGAGGACACCUCUUCAG
|
Percentage efficacy of ASP-siRNA for wild allele: | 5
|
Relative difference: | NA
|
Wild siRNA details |
Wild allele (5'->3'): | UGACUCCUGAGGAGAAGUC
|
Wild siRNA (As strand 3'->5'): | ACUGAGGACUCCUCUUCAG
|
Percentage efficacy of wild siRNA for wild allele: | NA
|
Wild allele (5'->3'): | UGACUCCUGAGGAGAAGUC
|
ASP-siRNA (As strand 3'->5'): | ACUGAGGACACCUCUUCAG
|
Percentage efficacy of Wild sirna for mutant allele: | NA
|
Relative difference : | NA
|
General information |
Mismatch incorporated in siRNA/Target: | siRNA |
Cell-line used: | HeLa |
Experimental technique used: | Dual luciferase reporter assay |
Transfection method: | Lipofectamine 2000 |
siRNA expression method: | Dharmacon |
Post-transfection duration: | 48 hours |
Concentration used: | 200nM |
Reference: | 16585504 |
Delivery method: | Transfection |
'Article title: | Determinants of specific RNA interference-mediated silencing of human beta-globin alleles differing by a single nucleotide polymorphism. |
'Authors: | Dykxhoorn DM, Schlehuber LD, London IM, Lieberman J. |
'Journal Reference: | Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5953-8. Epub 2006 Apr 3. |
'